Author

Ritik Thumar

Indian Institute of Advanced Research

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Bioinformatics· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Approach:mixed model· 1 Assay:protein sequence· 1 Assay:protein structure· 1 Approach:statistical model· 1 Organism:virus· 1

Frequent Co-Authors

Dhaval PateliD· 2 shared Meet Parmar· 2 shared Bhumi Patel· 1 shared Jigar Sheth· 1 shared Mohd AthariD· 1 shared Prakash Chandra JhaiD· 1 shared

Activity by Year

2021-2022 · peak 1/yr

Co-Author Collaboration Network

6 top collaborators · 12 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersBioinformatics

Dhaval PatelORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Designing multi-epitope based peptide vaccine targeting spike protein SARS-CoV-2 B1.1.529 (Omicron) variant using computational approaches.

Meet Parmar, Ritik Thumar, Jigar Sheth, Dhaval Patel

This study designs a multi-epitope peptide vaccine targeting the SARS-CoV-2 Omicron variant using computational methods to predict epitopes and evaluate vaccine properties.

Structural Chemistry · Sep 19, 2022Peer-reviewedBioinformatics

Structural Differences In 3C-like protease (Mpro) From SARS-CoV and SARS-CoV-2: Molecular Insights For Drug Repurposing Against COVID-19 Revealed by Molecular Dynamics Simulations.

Meet Parmar, Ritik Thumar, Bhumi Patel, Mohd Athar, Prakash Chandra Jha, Dhaval Patel

This paper compares SARS-CoV-2 and SARS-CoV Mpro using molecular dynamics simulations to assess structural differences and their impact on drug repurposing for COVID-19.

bioRxiv · Aug 11, 2021 · PreprintBioinformatics